| Previous close | 35.03 |
| Open | 35.02 |
| Bid | 32.15 |
| Ask | 36.30 |
| Strike | 92.50 |
| Expiry date | 2025-01-17 |
| Day's range | 35.02 - 35.03 |
| Contract range | N/A |
| Volume | |
| Open interest | 70 |
ReutersGlenview to meet top CVS execs, propose operational improvements, WSJ reports
The hedge fund's founder, Larry Robbins, has built a large position in CVS, which amounts to about $700 million of his $2.5 billion hedge fund, the report said, citing a person familiar with the matter. CVS said it "maintains a regular dialogue with the investment community as part of our robust shareholder and analyst engagement program," and said it can't comment on engagement with specific firms or individuals. Glenview did not immediately respond to a Reuters' request for comment.
ZacksCVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
ZacksNew Strong Sell Stocks for September 27th
ASO, AVD and CVS have been added to the Zacks Rank #24 (Strong Sell) List on September 27, 2024.
